Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
NCT: NCT07168564 · COMPLETED
Brief Summary
The goal of this clinical trial is to assess improvements in visual performance and patient outcomes in wearing new spectacle lenses in general population. The two spectacle lenses will be compared after two weeks of wearing. The aims are: * to evaluate the visual superiority, and quality-of-life implications of Essilor® AVA™ spectacle lenses prescribed after a new subjective refraction protocol named AVA™ protocol. * to understand the benefits of using a high accuracy instrument and testing sequence over the standard testing sequence in determining a glasses prescription, as well as the overall subjective performance of the resulting glasses.
Frequently Asked Questions
What is Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol?
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol is a clinical trial registered under NCT07168564. Current status: COMPLETED.
What is the status of NCT07168564?
The current status of NCT07168564 (Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol) is: COMPLETED.
When did Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol start?
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol started on 2025-09-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.